APA

Low J. D., Bartberger M. D., Chen K., Cheng Y., Fielden M. R., Gore V., Hickman D., Liu Q., Allen Sickmier E., Vargas H. M., Werner J., White R. D., Whittington D. A., Wood S. & Minatti A. E. (2017). Development of 2-aminooxazoline 3-azaxanthene β-amyloid cleaving enzyme (BACE) inhibitors with improved selectivity against Cathepsin D. : MedChemComm.

Chicago

Low Jonathan D, Bartberger Michael D, Chen Kui, Cheng Yuan, Fielden Mark R, Gore Vijay, Hickman Dean, Liu Qingyian, Allen Sickmier E, Vargas Hugo M, Werner Jonathan, White Ryan D, Whittington Douglas A, Wood Stephen and Minatti Ana E. 2017. Development of 2-aminooxazoline 3-azaxanthene β-amyloid cleaving enzyme (BACE) inhibitors with improved selectivity against Cathepsin D. : MedChemComm.

Harvard

Low J. D., Bartberger M. D., Chen K., Cheng Y., Fielden M. R., Gore V., Hickman D., Liu Q., Allen Sickmier E., Vargas H. M., Werner J., White R. D., Whittington D. A., Wood S. and Minatti A. E. (2017). Development of 2-aminooxazoline 3-azaxanthene β-amyloid cleaving enzyme (BACE) inhibitors with improved selectivity against Cathepsin D. : MedChemComm.

MLA

Low Jonathan D, Bartberger Michael D, Chen Kui, Cheng Yuan, Fielden Mark R, Gore Vijay, Hickman Dean, Liu Qingyian, Allen Sickmier E, Vargas Hugo M, Werner Jonathan, White Ryan D, Whittington Douglas A, Wood Stephen and Minatti Ana E. Development of 2-aminooxazoline 3-azaxanthene β-amyloid cleaving enzyme (BACE) inhibitors with improved selectivity against Cathepsin D. : MedChemComm. 2017.